MedTrace Logo

Clusterin Level and Polycystic Ovary Syndrome

NCT06601725 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2024-09-19

No results posted yet for this study

Summary

Clusterin, a protein involved in metabolic syndrome, insulin resistance, and metabolic disorders associated with inflammation and oxidative stress such as atherosclerosis, Alzheimer's and some malignancies, has elevated levels in metabolic syndrome, PCOS, and the combination of these two groups. Clusterin could be used as an inflammatory marker to predict PCOS and metabolic syndrome.

Conditions

  • Polycystic Ovary Syndrome
  • Ovulation Disorder

Interventions

DIAGNOSTIC_TEST

Clusterin level

Clusterin plays a role in inflammation and oxidative stress processes such as metabolic syndrome, insulin resistance, and atherosclerosis

Sponsors & Collaborators

  • Sanliurfa Mehmet Akif Inan Education and Research Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-11-01
Completion
2021-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06601725 on ClinicalTrials.gov